Subscribe To
ETON / Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today?
ETON News
By GlobeNewsWire
October 30, 2023
Eton Pharmaceuticals to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023
DEER PARK, Ill., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), an innovative pharmaceutical company focused on developi more_horizontal
By Zacks Investment Research
September 12, 2023
Here's Why 'Trend' Investors Would Love Betting on Eton Pharmaceuticals, Inc. (ETON)
Eton Pharmaceuticals, Inc. (ETON) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently o more_horizontal
By Seeking Alpha
September 11, 2023
Eton Pharmaceuticals: Fading The Rally
Eton Pharmaceuticals, Inc. is a small specialty pharmaceutical company whose main product ALKINDI SPRINKLE is gaining market share. The stock has doub more_horizontal
By GlobeNewsWire
August 23, 2023
Eton Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference
DEER PARK, Ill., Aug. 23, 2023 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), an innovative pharmaceutical company focused on developin more_horizontal
By Zacks Investment Research
August 16, 2023
Eton Pharmaceuticals, Inc. (ETON) Hits Fresh High: Is There Still Room to Run?
Eton Pharmaceuticals, Inc. (ETON) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundament more_horizontal
By InvestorPlace
August 11, 2023
Why Is Eton Pharmaceuticals (ETON) Stock Up 30% Today?
Eton Pharmaceuticals (NASDAQ: ETON ) stock is soaring following the release of its earnings report for the second quarter of 2023! The big new exciti more_horizontal
By Seeking Alpha
August 10, 2023
Eton Pharmaceuticals, Inc. (ETON) Q2 2023 Earnings Call Transcript
Eton Pharmaceuticals, Inc. (NASDAQ:ETON ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants David Krempa - Chief Busine more_horizontal
By Zacks Investment Research
August 10, 2023
Eton Pharmaceuticals, Inc. (ETON) Tops Q2 Earnings and Revenue Estimates
Eton Pharmaceuticals, Inc. (ETON) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per sha more_horizontal